ArticleSeminars in arthritis and rheumatism2020

RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs.

Gabriela Schmajuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.